|
186 Products |
| 186 Products |
|
1696 Diseases |  |
94663 News |  |
| «12...10281029103010311032103310341035103610371038...10631064» |
- methylprednisolone acetate / Generic mfg.
Clinical: Sodium Hyaluronate Injection and Corticosteroids in Trochanteric Bursitis: a Randomized Controlled Study. (clinicaltrials.gov) - Jan 16, 2014
P3, N=30, Not yet recruiting, Sponsor: Universitaire Ziekenhuizen Leuven
- | Riarify (beclometasone/formoterol/glycopyrrolate) / Chiesi
New P1 trial: TRIPLE10: A Study to Investigate the Pharmacokinetics, Safety and Tolerability of CHF 5993 pMDI in Subjects With Renal Impairment. (clinicaltrials.gov) - Jan 16, 2014
P1, N=48, Not yet recruiting, Sponsor: Chiesi Farmaceutici S.p.A.
- |||| Ninlaro (ixazomib) / Takeda
Trial completion, Combination therapy: A Study of Ixazomib Administered in Combination With Lenalidomide and Low-Dose Dexamethasone in Patients With Newly Diagnosed Multiple Myeloma (clinicaltrials.gov) - Jan 16, 2014
P1/2, N=65, Completed, Sponsor: Millennium Pharmaceuticals, Inc.
Active, not recruiting --> Completed
- || fluticasone propionate/salmeterol xinafoate inhalation powder / Generic mfg.
Enrollment change, Adverse events: Pharmacovigilance Study to Evaluate Safety of SERETIDE in Participants With Chronic Obstructive Pulmonary Disease (COPD) (clinicaltrials.gov) - Jan 15, 2014
P=N/A, N=762, Completed, Sponsor: GlaxoSmithKline
Active, not recruiting --> Completed N=1000 --> 762
- ||| fluticasone propionate/salmeterol xinafoate inhalation powder / Generic mfg.
Trial completion, Adverse events: Pharmacovigilance Study to Evaluate Safety of SERETIDE in Participants With Chronic Obstructive Pulmonary Disease (COPD) (clinicaltrials.gov) - Jan 15, 2014
P=N/A, N=762, Completed, Sponsor: GlaxoSmithKline
N=1000 --> 762 Active, not recruiting --> Completed
- dexamethasone / Generic mfg.
Enrollment open: Dexamethasone Infusion to the Adventitia to Enhance Clinical Efficacy After Femoropopliteal Revascularization (clinicaltrials.gov) - Jan 15, 2014
P=N/A, N=30, Recruiting, Sponsor: University of California, San Francisco
Active, not recruiting --> Completed Active, not recruiting --> Recruiting
- | Avastin (bevacizumab) / Roche
Enrollment closed, Combination therapy, Metastases: Lower Dose Chemotherapy Given More Frequent With Avastin to Treat Advanced Non-Squamous Non-Small Cell Lung Cancer (clinicaltrials.gov) - Jan 15, 2014
P2, N=35, Active, not recruiting, Sponsor: University of Alabama at Birmingham
Active, not recruiting --> Recruiting Recruiting --> Active, not recruiting
- ||| ALD 401 / Nuo Therapeutics
Enrollment closed: Study of ALD-401 Via Intracarotid Infusion in Ischemic Stroke Subjects (clinicaltrials.gov) - Jan 13, 2014
P2, N=100, Active, not recruiting, Sponsor: Aldagen
Recruiting --> Active, not recruiting Recruiting --> Active, not recruiting
- Zoptrex (zoptarelin doxorubicin) / AEterna Zentaris
Trial termination, Metastases: Phase 2 Trial of AEZS-108 in Chemotherapy Refractory in Triple Negative Breast Cancer (clinicaltrials.gov) - Jan 13, 2014
P2, N=7, Terminated, Sponsor: AEterna Zentaris
Recruiting --> Active, not recruiting Recruiting --> Terminated; Poor recruitment
- Zoptrex (zoptarelin doxorubicin) / AEterna Zentaris
Enrollment change, Metastases: Phase 2 Trial of AEZS-108 in Chemotherapy Refractory in Triple Negative Breast Cancer (clinicaltrials.gov) - Jan 13, 2014
P2, N=7, Terminated, Sponsor: AEterna Zentaris
Recruiting --> Terminated; Poor recruitment N=74 --> 7
- dexamethasone injection / Generic mfg.
Enrollment open: Pilot Trial on Efficacy of Single Dose Perioperative Intravenous Dexamethasone for Pain Relief After Endoscopic Submucosal Dissection (clinicaltrials.gov) - Jan 13, 2014
P=N/A, N=50, Recruiting, Sponsor: Yonsei University
N=74 --> 7 Not yet recruiting --> Recruiting
- | quisinostat (JNJ 26481585) / ChemRar, Viriom
Trial completion, Combination therapy, Epigenetic controller: A Dose Escalation Study of the Histone Deacetylase Inhibitor (HDACi) JNJ 26481585 in Combination With VELCADE (Bortezomib) and Dexamethasone for Patients With Relapsed Multiple Myeloma (clinicaltrials.gov) - Jan 13, 2014
P1, N=18, Completed, Sponsor: Janssen Research & Development, LLC
Not yet recruiting --> Recruiting Active, not recruiting --> Completed
- | dexamethasone / Generic mfg.
Enrollment open: Comparison of a Bilateral TAP Block and Preperitoneal Instillation of Local Anesthetic for a Total Extraperitoneal (TEP) Repair (clinicaltrials.gov) - Jan 12, 2014
P3, N=75, Recruiting, Sponsor: Indiana University School of Medicine
Active, not recruiting --> Completed Not yet recruiting --> Recruiting
- ||||||| Incruse Ellipta (umeclidinium) / GSK
Trial completion: Efficacy and Safety of the Addition of Fluticanse Propionate/Salmeterol (250/50mcg) Twice-daily to 2 Doses of Umeclidinium Bromide (62.5 or 125mcg) Once-daily Over 12 Weeks (clinicaltrials.gov) - Jan 8, 2014
P3, N=617, Completed, Sponsor: GlaxoSmithKline
Not yet recruiting --> Recruiting Active, not recruiting --> Completed
- prednisone / Generic mfg.
Enrollment change: Single Oral Dose of Dexamethasone Versus Five Days of Prednisone in Adult Asthma (clinicaltrials.gov) - Jan 7, 2014
P4, N=480, Recruiting, Sponsor: Alameda County Medical Center
Active, not recruiting --> Completed N=370 --> 480
- Seprehvir (HSV1716) / Sorrento
New P1 trial, Surgery: Oncolytic HSV-1716 in Treating Younger Patients With Refractory or Recurrent High Grade Glioma That Can Be Removed By Surgery (clinicaltrials.gov) - Jan 7, 2014
P1, N=24, Recruiting, Sponsor: Pediatric Brain Tumor Consortium
- Thymoglobulin (anti-thymocyte globulin (rabbit)) / Sanofi
Post-transplantation: BMT and High Dose Post-Transplant Cyclophosphamide for Chimerism Induction and Renal Allograft Tolerance (clinicaltrials.gov) - Jan 6, 2014
P2, N=6, Recruiting, Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
- Ibrance (palbociclib) / Pfizer
New P1 trial, Combination therapy: Palbociclib in Combination With Lenalidomide and Dexamethasone for Multiple Myeloma (clinicaltrials.gov) - Jan 6, 2014
P1, N=18, Not yet recruiting, Sponsor: Weill Medical College of Cornell University
- Seprehvir (HSV1716) / Sorrento
Enrollment open, Surgery: Oncolytic HSV-1716 in Treating Younger Patients With Refractory or Recurrent High Grade Glioma That Can Be Removed By Surgery (clinicaltrials.gov) - Jan 6, 2014
P1, N=24, Recruiting, Sponsor: Pediatric Brain Tumor Consortium
N=370 --> 480 Not yet recruiting --> Recruiting
- | Blincyto (blinatumomab) / Astellas, Amgen
Enrollment open: ECOG-ACRIN E1910: Combination Chemotherapy With or Without Blinatumomab in Treating Patients With Newly Diagnosed BCR-ABL-Negative B Lineage Acute Lymphoblastic Leukemia (clinicaltrials.gov) - Jan 5, 2014
P3, N=360, Recruiting, Sponsor: National Cancer Institute (NCI)
Not yet recruiting --> Recruiting Not yet recruiting --> Recruiting
- | hydrocortisone / Generic mfg.
Trial completion: An Investigational Study of Hydrocortisone (clinicaltrials.gov) - Jan 5, 2014
P1, N=14, Completed, Sponsor: Diurnal Limited
Not yet recruiting --> Recruiting Recruiting --> Completed
- cisplatin / Generic mfg.
Trial termination: Aprepitant in the Prevention of Cisplatin-induced Delayed Emesis (clinicaltrials.gov) - Jan 2, 2014
P3, N=303, Terminated, Sponsor: S. Maria Hospital, Terni
Recruiting --> Completed Recruiting --> Terminated; we terminated the study before enrolling 303/560 due to a slow accrual
- cisplatin / Generic mfg.
Enrollment change: Aprepitant in the Prevention of Cisplatin-induced Delayed Emesis (clinicaltrials.gov) - Jan 2, 2014
P3, N=303, Terminated, Sponsor: S. Maria Hospital, Terni
Recruiting --> Terminated; we terminated the study before enrolling 303/560 due to a slow accrual N=560 --> 303
- | bortezomib / Generic mfg., cyclophosphamide / Generic mfg.
New P2 trial: Combination of G-CSF, Bortezomib, Cyclophosphamide and Dexamethasone in Patients With Multiple Myeloma (clinicaltrials.gov) - Jan 2, 2014
P2, N=60, Recruiting, Sponsor: The Second Affiliated Hospital of Soochow University
- Zolinza (vorinostat) / Merck (MSD)
Enrollment closed: Vorinostat With Gemcitabine, Busulfan, and Melphalan With Stem Cell Transplant (SCT) in Relapsed or Refractory Lymphoid Malignancies (clinicaltrials.gov) - Jan 2, 2014
P1, N=80, Active, not recruiting, Sponsor: M.D. Anderson Cancer Center
N=560 --> 303 Recruiting --> Active, not recruiting
- Promacta (eltrombopag) / Novartis
Trial completion: Eltrombopag and High-dose Dexamethasone as First Line Treatment for IT (clinicaltrials.gov) - Jan 2, 2014
P2, N=30, Completed, Sponsor: Hospital Universitario Dr. Jose E. Gonzalez
Recruiting --> Active, not recruiting Recruiting --> Completed
- triamcinolone acetonide topical / Generic mfg.
Trial termination: Treatment of Early Nasal Polyposis With Topical Triamcinolone (clinicaltrials.gov) - Jan 1, 2014
P2, N=2, Terminated, Sponsor: Steward St. Elizabeth's Medical Center of Boston, Inc.
Recruiting --> Completed Recruiting --> Terminated; not enough particpants
- triamcinolone acetonide topical / Generic mfg.
Enrollment change: Treatment of Early Nasal Polyposis With Topical Triamcinolone (clinicaltrials.gov) - Jan 1, 2014
P2, N=2, Terminated, Sponsor: Steward St. Elizabeth's Medical Center of Boston, Inc.
Recruiting --> Terminated; not enough particpants N=100 --> 2
- | salmeterol/fluticasone easyhaler / Orion Corp
Trial completion: Comparison of Salmeterol and Fluticasone Propionate Absorption From Salmeterol/Fluticasone Easyhaler With Seretide Diskus (clinicaltrials.gov) - Jan 1, 2014
P1, N=48, Completed, Sponsor: Orion Corporation, Orion Pharma
N=100 --> 2 Recruiting --> Completed
- | salmeterol/fluticasone easyhaler / Orion Corp
Trial completion: Comparison of Salmeterol and Fluticasone Propionate Absorption From Salmeterol/Fluticasone Easyhaler and Seretide Diskus (clinicaltrials.gov) - Jan 1, 2014
P1, N=50, Completed, Sponsor: Orion Corporation, Orion Pharma
Recruiting --> Completed Recruiting --> Completed
- Genasense (oblimersen) / Genta
Trial completion: Dexamethasone With or Without Oblimersen in Treating Patients With Relapsed or Refractory Multiple Myeloma (clinicaltrials.gov) - Jan 1, 2014
P3, N=0, Completed, Sponsor: Genta Incorporated
Recruiting --> Completed Active, not recruiting --> Completed
- dexamethasone / Generic mfg.
New P4 trial, Surgery: Analgesic Effect of Intra-articular Dexamethasone and Dexamethasone Added to Bupivacaine in Interscalene Brachial Plexus (clinicaltrials.gov) - Dec 30, 2013
P4, N=40, Recruiting, Sponsor: TC Erciyes University
- || budesonide inhalation suspension / Generic mfg.
New P2/3 trial: Effects and Safety of Budesonide Inhalation Suspension Via Transnasal Nebulization in Nasal Polyps (clinicaltrials.gov) - Dec 29, 2013
P2/3, N=60, Recruiting, Sponsor: Beijing Tongren Hospital
- | dexamethasone / Generic mfg.
New P4 trial: Ultrasound Guided Trigeminal Nerve Block for Typical or Atypical Facial Pain (clinicaltrials.gov) - Dec 29, 2013
P4, N=60, Recruiting, Sponsor: Northwestern University
- || 5-fluorouracil / Generic mfg.
New P3 trial: Local 5-Fluorouracil Injection for the Treatment of Chalazia: A Prospective, Comparative Study (clinicaltrials.gov) - Dec 29, 2013
P3, N=120, Recruiting, Sponsor: University of Washington
- triamcinolone acetonide / Generic mfg.
New P4 trial: Trigger Point Injections and Pelvic Rehabilitation for the Treatment of Pelvic Floor Myalgia and Sexual Pain (clinicaltrials.gov) - Dec 26, 2013
P4, N=36, Recruiting, Sponsor: University of Cincinnati
- | Neupogen (filgrastim) / Kyowa Kirin, Amgen
Clinical: Donor Lymphocyte Infusion (DLI) of T-cells Genetically Modified With iCasp9 Suicide Gene (clinicaltrials.gov) - Dec 26, 2013
P1/2, N=35, Recruiting, Sponsor: M.D. Anderson Cancer Center
Active, not recruiting --> Completed Not yet recruiting --> Recruiting
- ||| fluticasone propionate/salmeterol xinafoate inhalation powder / Generic mfg.
Trial completion: Effects of Inhaled Corticosteroids on Sputum Bacterial Load in COPD (clinicaltrials.gov) - Dec 26, 2013
P=N/A, N=60, Completed, Sponsor: Università degli Studi di Ferrara
Not yet recruiting --> Recruiting Recruiting --> Completed
- | dexamethasone / Generic mfg.
New P4 trial, Surgery: Prevention of Nausea and Vomiting in Patients After Surgery (clinicaltrials.gov) - Dec 25, 2013
P4, N=67, Completed, Sponsor: Yeditepe University Hospital
- || ketamine / Generic mfg.
New P3 trial, Surgery: Ketamine in Post-operative Dental Pain and Recovery (clinicaltrials.gov) - Dec 25, 2013
P3, N=150, Not yet recruiting, Sponsor: The University of Hong Kong
- carfilzomib / Generic mfg.
Clinical: Carfilzomib in Treating Patients With Multiple Myeloma in First Relapse or Refractory to First-Line Therapy (clinicaltrials.gov) - Dec 23, 2013
P2, N=35, Recruiting, Sponsor: Indiana University School of Medicine
- Zolinza (vorinostat) / Merck (MSD)
Trial termination, Combination therapy: LenVoDex: Lenalidomide, Vorinostat and Dexamethasone in Relapsed Patients With Peripheral T-Cell Non-Hodgkin's Lymphoma (PTCL) (clinicaltrials.gov) - Dec 22, 2013
P1/2, N=20, Terminated, Sponsor: Arbeitsgemeinschaft medikamentoese Tumortherapie
Recruiting --> Completed Recruiting --> Terminated; slow recruitment
- ||| Trial completion: Phase I Study Evaluating the Safety and Pharmacokinetics of Budesonide, Glycopyrronium, and Formoterol Fumarate Inhalation Aerosol (BGF MDI) in Healthy Volunteers (clinicaltrials.gov) - Dec 22, 2013
P1, N=84, Completed, Sponsor: Pearl Therapeutics, Inc.
Recruiting --> Terminated; slow recruitment Active, not recruiting --> Completed
- | Dexilant (dexlansoprazole) / Takeda
Trial completion: Study of the Efficiency of Esophageal Dilation on Patient With Eosinophilic Esophagitis (clinicaltrials.gov) - Dec 19, 2013
P=N/A, N=50, Completed, Sponsor: Vanderbilt University
Active, not recruiting --> Completed Recruiting --> Completed
- |||| erlotinib / Generic mfg.
Trial completion, Metastases: LUTRAERL: Systemic and Topical Treatments for Rash Secondary to Erlotinib in Lung Cancer (clinicaltrials.gov) - Dec 18, 2013
P2, N=150, Completed, Sponsor: British Columbia Cancer Agency
Recruiting --> Completed Active, not recruiting --> Completed
- |||| Vesanoid (tretinoin) / Roche
Enrollment open: Revlimid / All-Trans Retinoic Acid (ATRA) / Dexamethasone in Relapsed/Refractory Multiple Myeloma (clinicaltrials.gov) - Dec 17, 2013
P1/2, N=70, Recruiting, Sponsor: M.D. Anderson Cancer Center
Active, not recruiting --> Completed Not yet recruiting --> Recruiting
- |||| ondansetron / Generic mfg., aprepitant oral / Generic mfg., dexamethasone injection / Generic mfg.
Trial completion, Surgery: Combination Antiemetic Regimen for Prevention of PONV in Breast Surgery Patients (clinicaltrials.gov) - Dec 17, 2013
P4, N=100, Completed, Sponsor: Scott and White Hospital & Clinic
Not yet recruiting --> Recruiting Recruiting --> Completed
- | Korlym (mifepristone) / Corcept Therap
New P1 trial, Combination therapy, Metastases: Mifepristone and Eribulin in Patients With Metastatic Triple Negative Breast Cancer or Other Specified Solid Tumors (clinicaltrials.gov) - Dec 16, 2013
P1, N=40, Recruiting, Sponsor: Corcept Therapeutics
- | bortezomib / Generic mfg., melphalan / Generic mfg.
Enrollment closed: Bortezomib and Dexamethasone Followed by High-Dose Melphalan and Stem Cell Transplantation for Primary (AL) Amyloidosis (clinicaltrials.gov) - Dec 16, 2013
P2, N=30, Active, not recruiting, Sponsor: Boston Medical Center
Recruiting --> Completed Recruiting --> Active, not recruiting
- ||||| Ultibro (glycopyrronium/indacaterol) / Novartis
Trial initiation date: A 26-week Treatment Randomized, Double-blind, Double Dummy Study to Assess the Efficacy and Safety of QVA149 (clinicaltrials.gov) - Dec 15, 2013
P3, N=741, Active, not recruiting, Sponsor: Novartis Pharmaceuticals
Recruiting --> Active, not recruiting Initiation date: Apr 2012 --> Nov 2012